"Dengue Fever Clinical Trials"DelveInsight's,“Dengue Fever - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Dengue Fever pipeline landscape ...
WALTHAM, Mass.--(BUSINESS WIRE)--EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Dengue Vaccines: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug ...
Dengue virus (DENV) is a human pathogen with a large impact on public health. Although no vaccine against DENV is currently licensed, a recombinant vaccine — chimeric yellow fever virus–DENV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results